Geneos Wealth Management’s DocuSign DOCU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $71.7K | Hold |
1,615
| – | – | ﹤0.01% | 1344 |
|
|
2026
Q1 | $76.6K | Sell |
1,615
-826
| -34% | -$42.3K | ﹤0.01% | 1264 |
|
|
2025
Q4 | $167K | Buy |
2,441
+51
| +2% | +$3.53K | ﹤0.01% | 979 |
|
|
2025
Q3 | $172K | Sell |
2,390
-25
| -1% | -$1.93K | ﹤0.01% | 949 |
|
|
2025
Q2 | $188K | Buy |
2,415
+536
| +29% | +$43.4K | ﹤0.01% | 1017 |
|
|
2025
Q1 | $153K | Buy |
1,879
+7
| +0.4% | +$613 | 0.01% | 1016 |
|
|
2024
Q4 | $168K | Sell |
1,872
-1,597
| -46% | -$128K | 0.01% | 897 |
|
|
2024
Q3 | $215K | Hold |
3,469
| – | – | 0.01% | 752 |
|
|
2024
Q2 | $186K | Buy |
3,469
+25
| +0.7% | +$1.41K | 0.01% | 719 |
|
|
2024
Q1 | $205K | Hold |
3,444
| – | – | 0.01% | 696 |
|
|
2023
Q4 | $205K | Sell |
3,444
-182
| -5% | -$8.35K | 0.01% | 668 |
|
|
2023
Q3 | $152K | Sell |
3,626
-683
| -16% | -$33.5K | 0.01% | 753 |
|
|
2023
Q2 | $220K | Sell |
4,309
-417
| -9% | -$22.1K | 0.01% | 662 |
|
|
2023
Q1 | $276K | Sell |
4,726
-182
| -4% | -$10.9K | 0.02% | 573 |
|
|
2022
Q4 | $272K | Sell |
4,908
-235
| -5% | -$11.4K | 0.02% | 563 |
|
|
2022
Q3 | $274K | Sell |
5,143
-1,484
| -22% | -$93K | 0.02% | 522 |
|
|
2022
Q2 | $405K | Buy |
6,627
+3,822
| +136% | +$309K | 0.02% | 552 |
|
|
2022
Q1 | $300K | Buy |
2,805
+534
| +24% | +$61.3K | 0.01% | 669 |
|
|
2021
Q4 | $345K | Buy |
2,271
+273
| +14% | +$62.2K | 0.01% | 687 |
|
|
2021
Q3 | $515K | Sell |
1,998
-110
| -5% | -$31.7K | 0.02% | 561 |
|
|
2021
Q2 | $587K | Sell |
2,108
-212
| -9% | -$47.4K | 0.02% | 524 |
|
|
2021
Q1 | $517K | Sell |
2,320
-486
| -17% | -$113K | 0.01% | 626 |
|
|
2020
Q4 | $506K | Buy |
2,806
+455
| +19% | +$102K | 0.02% | 536 |
|
|
2020
Q3 | $499K | Buy |
2,351
+11
| +0.5% | +$2.28K | 0.03% | 429 |
|
|
2020
Q2 | $415K | Buy |
2,340
+1,295
| +124% | +$163K | 0.02% | 451 |
|
|
2020
Q1 | $86K | Buy |
1,045
+200
| +24% | +$16.1K | 0.01% | 889 |
|
|
2019
Q4 | $62K | Hold |
845
| – | – | ﹤0.01% | 1148 |
|
|
2019
Q3 | $51K | Sell |
845
-749
| -47% | -$39.2K | ﹤0.01% | 1168 |
|
|
2019
Q2 | $79K | Buy |
1,594
+420
| +36% | +$22.4K | ﹤0.01% | 994 |
|
|
2019
Q1 | $60K | Buy |
1,174
+749
| +176% | +$38.2K | ﹤0.01% | 1059 |
|
|
2018
Q4 | $17K | Buy |
425
+120
| +39% | +$5.04K | ﹤0.01% | 1564 |
|
|
2018
Q3 | $16K | Buy |
305
+130
| +74% | +$7.37K | ﹤0.01% | 1669 |
|
|
2018
Q2 | $9K | Buy |
+175
| New | +$8.83K | ﹤0.01% | 1752 |
|
Other funds holding DOCU
Geneos Wealth Management's DOCU Position: Q2 2026 in Review
Geneos Wealth Management held its DocuSign (DOCU) position steady in Q2 2026 at 1,615 shares worth $71.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1344.
Geneos Wealth Management first reported a position in DOCU in Q2 2018 and has held it in 33 quarters since. The position peaked at $587K in Q2 2021. 674 funds tracked by Wall St. Rank hold DOCU as of Q2 2026.
- Geneos Wealth Management held 1,615 shares of DocuSign worth $71.7K as of Q2 2026.
- Geneos Wealth Management left its DocuSign share count unchanged in Q2 2026.
- DocuSign made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1344 holding.
- Geneos Wealth Management first reported a position in DocuSign in Q2 2018 and has held it in 33 quarters since.
- Geneos Wealth Management's DocuSign position peaked at $587K in Q2 2021.
- 674 funds tracked by Wall St. Rank held DocuSign as of Q2 2026.
Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.